Mobilizing Health Support for Women Victims of Violence – Agence Régionale de Santé Ile-de-France
Agence Régionale de Santé Ile-de-France shared a post on LinkedIn:
“Santé and Women | The ARS Île-de-France is mobilizing for women victims of violence
Violence against women, whether physical, sexual, psychological or verbal, has profound consequences on health, often invisible, but lasting.
To respond to this, the Agence Régionale de Santé Ile-de-France is strengthening health support for women through a key mechanism: the Women’s Houses / Health.
These places, integrated into hospitals, offer comprehensive, confidential and secure care. Each woman is welcomed with listening, respect and kindness by a multidisciplinary team: midwives, doctors, psychologists, social workers, lawyers, etc.
In 2025, 13 hospital facilities are supported by the ARS, covering all the departments of the Ile-de-France region, to guarantee equitable access to these essential resources.
Discover our report at the Casavia center, located in La Pitié-Salpêtrière, Greater Paris University Hospitals – AP-HP
Learn more.”
Proceed to the video attached to the post.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 1, 2026, 13:32Pregnancy Loss Leave and Recognition in Ireland! – PLRG
-
Apr 1, 2026, 13:19Christopher Robinson: Immune Tolerance Breakdown In Pregnancy!
-
Apr 1, 2026, 13:14How Many Cells Are Enough in Blastocyst Biopsy? – Fertility Plus
-
Apr 1, 2026, 13:09Follicular Fluid PFAS May Influence IVF Outcomes – Fertility and Sterility
-
Apr 1, 2026, 12:48Taarika Ramesh: Rethinking IVF Stimulation With Progestin-Primed Protocols
-
Apr 1, 2026, 12:41Shivam Jha: What is the Importance of Ultrasound During Pregnancy?
-
Apr 1, 2026, 12:18Abnormal Spermogram Is Not an Explanation, It Is a Starting Point – Cesar Fertility
-
Apr 1, 2026, 11:41Christopher Robinson: Racial Disparities in Postoperative Benign Hysterectomy Outcomes
-
Apr 1, 2026, 11:26Sergei Gorlovetsky: Most Fertility Clinics Are Losing Patients Between Interested and Started Treatment
